Monday 17 November
Improving endpoints in glaucoma trials-How do we best decide what works? Prof Gus GazzardIn the last few years, especially with the industry-driven innovation leading to the rise of minimally invasive glaucoma procedures, what is considered 'success' has widened but could, should we do better?
Publication Details
- Journal
- Clinical and Experimental Ophthalmology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/ceo.70047
- Primary Topic
- Legal case studies and regulations
- Type
- article
- Field-Weighted Citation Impact
- 0.00